We are live on
!
Find out more
CCA
Catalyst Capital Advisors Portfolio holdings
AUM
$6.03B
1-Year Est. Return
24.5%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+24.5%
3 Year Est. Return
+62.66%
5 Year Est. Return
+62.45%
10 Year Est. Return
+241.55%
AUM
$872M
AUM Growth
+$19.8M
(+2.3%)
Cap. Flow
+$16.5M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
18.4%
Holding
619
New
128
Increased
115
Reduced
79
Closed
181
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$20.3M |
| 2 |
Delta Air Lines
DAL
|
+$16.9M |
| 3 |
S
Sprint Corporation
S
|
+$15.9M |
| 4 |
Enovis
ENOV
|
+$14.7M |
| 5 |
SWN
Southwestern Energy Company
SWN
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$21.7M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$19.8M |
| 3 |
Flex
FLEX
|
+$17.9M |
| 4 |
Synchrony
SYF
|
+$15.3M |
| 5 |
Boston Scientific
BSX
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.85% |
| 2 | Industrials | 13.14% |
| 3 | Consumer Discretionary | 12.72% |
| 4 | Technology | 12.14% |
| 5 | Energy | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Targa Resources
TRGP
$60.4B
| $504K | 0.06% |
5,266
+3,867
| +276% | +$363K |
|
|
ESL
202
DELISTED
Esterline Technologies
ESL
| $503K | 0.06% |
+4,400
| New | +$497K |
|
|
BBG
203
DELISTED
Bill Barrett Corp
BBG
| $498K | 0.06% |
60,000
-230,000
| -79% | -$2.35M |
|
|
LO
204
DELISTED
LORILLARD INC COM STK
LO
| $490K | 0.06% |
7,500
| – | – |
|
|
TAL
205
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
| $489K | 0.06% |
+12,000
| New | +$498K |
|
206
Brown-Forman Class B
BF.B
$12B
| $488K | 0.06% |
+16,875
| New | +$486K |
|
|
GRA
207
DELISTED
W.R. Grace & Co.
GRA
| $482K | 0.06% |
+4,875
| New | +$465K |
|
208
Myriad Genetics
MYGN
$530M
| $481K | 0.06% |
13,600
+6,098
| +81% | +$218K |
|
209
Plains GP Holdings
PAGP
$5.23B
| $481K | 0.06% |
6,368
+4,294
| +207% | +$312K |
|
210
Chemed
CHE
$6.78B
| $478K | 0.05% |
+4,000
| New | +$444K |
|
211
McCormick & Company Non-Voting
MKC
$13.4B
| $478K | 0.05% |
+12,400
| New | +$460K |
|
|
FINL
212
DELISTED
Finish Line
FINL
| $478K | 0.05% |
+19,500
| New | +$469K |
|
|
FLIR
213
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $477K | 0.05% |
+15,250
| New | +$481K |
|
|
MEG
214
DELISTED
Media General, Inc
MEG
| $474K | 0.05% |
28,750
+13,750
| +92% | +$214K |
|
|
BNY
215
Bank of New York Mellon
BNY
$108B
| $473K | 0.05% |
11,750
-56,250
| -83% | -$2.19M |
|
216
PepsiCo
PEP
$186B
| $473K | 0.05% |
+4,950
| New | +$479K |
|
217
Lowe's Companies
LOW
$116B
| $469K | 0.05% |
+6,300
| New | +$452K |
|
|
BIG
218
DELISTED
Big Lots, Inc.
BIG
| $468K | 0.05% |
+9,750
| New | +$460K |
|
219
PNC Financial Services
PNC
$100B
| $466K | 0.05% |
+5,000
| New | +$451K |
|
|
ONCE
220
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $465K | 0.05% |
+6,000
| New | +$346K |
|
221
General Motors
GM
$74.7B
| $461K | 0.05% |
+12,300
| New | +$447K |
|
222
Valmont Industries
VMI
$9.44B
| $461K | 0.05% |
+3,750
| New | +$460K |
|
|
ENLC
223
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $461K | 0.05% |
14,158
+10,231
| +261% | +$339K |
|
224
Merck
MRK
$324B
| $460K | 0.05% |
+8,384
| New | +$475K |
|
225
State Street
STT
$50.9B
| $460K | 0.05% |
+6,250
| New | +$468K |
|
Similar funds
RCG
WHRC
EAM
AAM
CM
HPG
EMPI
GA
Catalyst Capital Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Catalyst Capital Advisors held 619 positions worth $872M, up 2.3% from $852M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Catalyst Capital Advisors's Q1 2015 filing shows 128 new, 115 increased, 79 reduced and 181 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 200,250 shares worth $20.9M. The largest sale was Bausch Health, an estimated $21.7M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Catalyst Capital Advisors's largest Q1 2015 buy was Alnylam Pharmaceuticals: 200,250 shares worth $20.9M.
- Catalyst Capital Advisors added most to Delta Air Lines in Q1 2015, an estimated $16.9M increase.
- Catalyst Capital Advisors's biggest Q1 2015 reduction was Bausch Health, cutting an estimated $21.7M.
- Catalyst Capital Advisors fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $19.8M.
- Catalyst Capital Advisors's ten largest holdings make up 18% of its $872M portfolio in Q1 2015.
- Catalyst Capital Advisors opened 128 new positions and closed 181 in Q1 2015.
- Catalyst Capital Advisors's portfolio value rose 2.3% quarter-over-quarter to $872M.
Based on Catalyst Capital Advisors's 13F filing for Q1 2015, filed 15 May 2015.